Handelsavisen
prelaunch
Companies Healthcare UNH.PS
UN
UNH.PS Healthcare Services & Equipment

Uniholdings Inc

$111,40
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
-9,8 %
Net margin
Debt / equity
1,55
Beta
52w range
Volume
Day range
Prev close
$423,38
Open
Next earnings
Ex-dividend
TR 1Y
About

Uniholdings Inc operates in the Real Estate Rental, Development & Operations industry, focusing on real estate rental, development, and operations.

Business. Uniholdings Inc (UNH.PS) operates in the Health Care sector, specifically within the Healthcare Services & Equipment industry. The company generates revenue through a rental-income model, consistent with real estate investment trust structures. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data.

Classification99 %
SectorHealth Care
Industry groupHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY30 analysts
24 buy6 hold0 sell
Avg 12m price target462,05

Analyst recommendations

30 analysts · consensus Buy
Buy24
Hold6
Sell0
12-month price target
462,05
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
30 analysts · indicative
Ownership
Vanguard Value ETF
largest disclosed fund holder
Profitability
-9,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning UNH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to UNH.PS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Uniholdings Inc (UNH.PS) operates in the Health Care sector, specifically within the Healthcare Services & Equipment industry. The company generates revenue through a rental-income model, consistent with real estate investment trust structures. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data.

    Classification99 %
    SectorHealth Care
    Industry groupHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Uniholdings Inc has a debt-to-equity ratio of 1.55, indicating a significant reliance on debt financing, and a current ratio of 0.17, suggesting limited short-term liquidity to cover immediate liabilities. The company's return on equity is -9.83%, and return on assets is -3.12%, both well below the industry median for profitability and capital efficiency.

    The company reported a net loss of PHP 122,653,540 and an operating loss of PHP 148,773,800 in the latest period, with no revenue recorded, which is a stark deviation from the industry's typical performance metrics. These figures indicate a severe underperformance in generating returns and managing operating costs relative to its peers.

    Uniholdings Inc's revenue concentration is not disclosed in the available data, but the absence of revenue in the latest financials suggests a potential overreliance on a single source or a significant operational disruption. The company's geographic exposure is also not specified, which limits the ability to assess regional risk or growth potential.

    The company's growth trajectory is negative, with no revenue recorded and a decline in operating and net income. Analysts have reported a last actual revenue of PHP 516,523,000, but the most recent financials show no revenue, indicating a potential reversal or reporting discrepancy. The company's free cash flow is negative at PHP -129,175,470, and operating cash flow is also negative at PHP -25,733,600, signaling cash flow constraints.

    Uniholdings Inc faces medium liquidity risk due to its negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, but the significant operating and net losses may pressure the need for additional capital, potentially leading to share dilution. The company's recent financial performance and negative cash flows are the primary risk factors affecting its valuation and operational stability.

    Recent events include the reporting of a last actual EPS of 23.23 PHP and a last actual revenue of PHP 516,523,000, which contrast sharply with the most recent financials showing no revenue and significant losses. These discrepancies may indicate a need for further investigation into the company's financial reporting practices or operational challenges.

    Key takeaways
    • Uniholdings Inc is experiencing severe financial distress, with no revenue and significant operating and net losses.
    • The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.55 and a current ratio of 0.17.
    • The company's profitability metrics, including return on equity and return on assets, are negative and far below industry norms.
    • The absence of revenue in the latest financials raises concerns about the company's operational sustainability and revenue concentration.
    • The company's liquidity position is weak, with negative net cash after subtracting total debt.
    • Recent analyst estimates suggest a discrepancy between reported and actual financial performance, warranting further scrutiny.
    • **margin_outlook_rationale**: The company's operating and net losses indicate a deteriorating margin outlook driven by operational inefficiencies and lack of revenue.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $111,40
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.25B
    Net cash
    -$1.93B
    Current ratio
    0.2
    Debt / equity
    1.6
    ROA
    -3.1%
    ROE
    -9.8%
    Cash conversion
    21.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Care Management Services
    low · business_description · 2026-07-04
    Commercial Health Insurance
    low · business_description · 2026-07-04
    Health Data Analytics
    low · business_description · 2026-07-04
    Health Financial Services
    low · business_description · 2026-07-04
    Pharmacy Care Services
    low · business_description · 2026-07-04

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryHealthcare Services & Equipment1 272,5B node revenueUNH 35,2%CI 21,6%ELV 15,7%CNC 13,7%HUM 10,2%MOH 3,6%PGNY 0,1%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)UNH 35,2% · rank #1 of 7

    Business relationships

    Business relationships10 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries10
    EX21:20e36d8a8b72EX21:20e36d8a8b72Subsidiarie97%
    EX21:2c43b795c176EX21:2c43b795c176Subsidiarie97%
    EX21:635c9d771ebfEX21:635c9d771ebfSubsidiarie97%
    EX21:81a6a5b1dc66EX21:81a6a5b1dc66Subsidiarie97%
    EX21:8336350d27c4EX21:8336350d27c4Subsidiarie97%
    EX21:a7d324a4b53eEX21:a7d324a4b53eSubsidiarie97%
    EX21:be4d17c9b725EX21:be4d17c9b725Subsidiarie97%
    EX21:d5e74dac487bEX21:d5e74dac487bSubsidiarie97%
    EX21:f7ed1b12e800EX21:f7ed1b12e800Subsidiarie97%
    EX21:fad2bbec7ebdEX21:fad2bbec7ebdSubsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    Peer comparison6 peers · vs UNH · multiples and returns
    CI
    CI
    The Cigna Group
    $280,25
    74,0B USD
    P/E
    13,1x
    -20,7 vs self
    Div yield
    2,1 %
    +0,2 vs self
    ROE
    14,0 %
    +2,4 vs self
    EL
    ELV
    Elevance Health Inc
    $382,77
    83,9B USD
    P/E
    14,6x
    -19,1 vs self
    Div yield
    vs self
    ROE
    12,6 %
    +1,0 vs self
    CN
    CNC
    Centene Corp
    $64,45
    31,9B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    -31,1 %
    -42,8 vs self
    HU
    HUM
    Humana Inc
    $363,19
    43,8B USD
    P/E
    39,5x
    +5,8 vs self
    Div yield
    0,9 %
    -1,0 vs self
    ROE
    6,4 %
    -5,2 vs self
    MO
    MOH
    Molina Healthcare Inc
    $194,77
    9,9B USD
    P/E
    24,4x
    -9,4 vs self
    Div yield
    vs self
    ROE
    11,6 %
    0,0 vs self
    PG
    PGNY
    Progyny Inc
    $31,53
    2,5B USD
    P/E
    34,0x
    +0,2 vs self
    Div yield
    vs self
    ROE
    11,3 %
    -0,3 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    18,41
    Predicted surprise
    -0,06
    Beat probability
    45 %
    Analysts
    30
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    revision ratio 0,00 · as of 2026-07-14 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-21 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$313,00
    Mean$462,05
    Median$470,00
    High$529,00
    Spot$111,40
    +314.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE-9,8 %Bottom quartile
    D/E1,55Bottom quartile
    Cash Conv0,21Below median

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-21 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • Uniholdings Inc Market data — financials · 2026-05-29
    • Uniholdings Inc Market data — analyst estimates · 2026-05-29

    Ownership & reference

    Top holders

    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-301,50 %$1M
    • Dodge & CoxInvestment Managers · as of 2026-03-311,41 %$2 562M
    • Nuveen LLCInvestment Managers · as of 2024-12-311,02 %$3 605M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,86 %$5 633M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,85 %$37 394M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,69 %$2 127M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,65 %$6M
    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,64 %$1M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,57 %$2 434M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,51 %$2 731M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,50 %$2 730M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,50 %$927M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,49 %$991M
    • Fisher InvestmentsInvestment Managers · as of 2026-03-310,48 %$1 417M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,44 %$30 238M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,42 %$12 266M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,38 %$6 140M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,38 %$1 535M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,31 %$2 376M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,28 %$1 353M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,28 %$2 121M
    • Invesco QQQ TrustFunds · as of 2026-03-310,26 %$1 709M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,25 %$806M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,24 %$4 049M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,22 %$947M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,20 %$368M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,18 %$908M
    • FMR LLCInstitutional Investor · as of 2026-03-310,17 %$3 252M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,17 %$934M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,14 %$236M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,13 %$259M
    • Jennison Associates LLCInvestment Managers · as of 2026-03-310,12 %$178M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,12 %$260M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,09 %$344M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,08 %$124M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,07 %$142M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,03 %$42M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$2M

    Insider activity

    Net selling0 buys · 1 sellsnet -$284K16 insiders · last 365d
    • Baker Charles D.Director · Common StockOther 220 · 2026-07-01
    • Noseworthy John HDirector · Common StockOther 206 · 2026-07-01
    • MONTGOMERY RICE VALERIE MDDirector · Common StockOther 220 · 2026-07-01
    • MCNABB FREDERICK WILLIAM IIIDirector · Common StockOther 250 · 2026-07-01
    • Gottlieb ScottDirector · Common StockOther 210 · 2026-07-01
    • Gil KristenDirector · Common StockOther 206 · 2026-07-01
    • GARCIA PAUL RDirector · Common StockOther 132 · 2026-07-01
    • GARCIA PAUL RDirector · Common StockOther 88 · 2026-07-01
    • FLYNN TIMOTHY PATRICKDirector · Common StockOther 225 · 2026-07-01
    • DeVeydt Wayne SChief Financial Officer · Common StockOther 112 · 2026-06-23
    • HEMSLEY STEPHEN JDirector, CEO, UHG · Common StockOther 46 · 2026-06-23
    • Baker Charles D.Director · Common StockOther 13 · 2026-06-23
    • MCNABB FREDERICK WILLIAM IIIDirector · Common StockOther 50 · 2026-06-23
    • FLYNN TIMOTHY PATRICKDirector · Common StockOther 61 · 2026-06-23
    • Conway Patrick HughChief Executive Officer, Optum · Common StockOther 82 · 2026-06-23
    • Stankiewicz Dennis AndrewChief Accounting Officer · Common StockOther 51 · 2026-06-23
    • McSweeney ErinEVP & Chief People Officer · Common StockOther 48 · 2026-06-23
    • Noseworthy John HDirector · Common StockOther 41 · 2026-06-23
    • GARCIA PAUL RDirector · Common StockOther 13 · 2026-06-23
    • MONTGOMERY RICE VALERIE MDDirector · Common StockOther 41 · 2026-06-23
    • Gil KristenDirector · Common StockOther 8 · 2026-06-23
    • Gottlieb ScottDirector · Common StockOther 3 · 2026-06-23
    • Noel Timothy JohnChief Executive Officer, UHC · Common StockOther 76 · 2026-06-23
    • Zaetta Christopher REVP & Chief Legal Officer · Common StockOther 61 · 2026-06-23
    • Conway Patrick HughChief Executive Officer, Optum · Common StockOther 687 @ $399,47$274K · 2026-06-05

    Short positioning

    17.3Mshares short-5.8% vs prior
    3.46days to cover
    37.1%short of daily vol
    425fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Held by funds 1

    • Vanguard Value ETFVanguard · ETF1,40 %130,0B $ · #22
    Funds (by AUM rank) that hold this security, with each fund's portfolio weight in this name.
    Index membership
    Dow Jones Industrial Average
    S&P 500United States

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    UNH.PSCanonical
    — · USD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,06M&A prob3 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    UNHEX21:20eEX21:2c4EX21:635EX21:81aEX21:833EX21:a7dEX21:be4EX21:d5eEX21:f7eEX21:fadHealthcare Ser
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Net margin (FY 2025-12-31): 2.7%Derived (calculated)
    • Return on assets (FY 2025-12-31): 3.9%Derived (calculated)
    • Current ratio (FY 2025-12-31): 0.79xDerived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): 3.5%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -3.7%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 8.5%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -15.1%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -14.7%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -0.1%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -16.3%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -18.6%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -41.3%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 11.8%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 3.8%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 6.2%Derived (calculated)
    • Operating income (annual): USD 18.96BSEC XBRL filing
    • Net income (annual): USD 12.06BSEC XBRL filing
    • Cost of revenue (annual): USD 50.66BSEC XBRL filing
    • Cash & equivalents (annual): USD 24.36BSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 13SEC XBRL filing
    • Interest expense (annual): USD 4BSEC XBRL filing
    • Operating cash flow (annual): USD 19.7BSEC XBRL filing
    • Pre-tax income (annual): USD 14.7BSEC XBRL filing
    • Revenue (annual): USD 447.57BSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-07-18 12:41 UTCNEWSUnitedHealth Group files 8-K on material agreement ahead of Q2 earnings → The filing signals a significant corporate development just one day before the insurer reports second-quarter results, adding a layer of scrutiny to its near-term outlook.
    2026-07-17 04:26 UTCFILINGMaterial 8-K
    2026-07-16 12:49 UTCNEWSHandelsavisen revises UnitedHealth Group thesis after sector classification audit → Internal data correction triggers fresh analysis of the insurer's valuation metrics and sector positioning.
    2026-07-16 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-16EVENTQ2 2026 earnings (expected) estimated date
    2026-07-15 07:40 UTCEVENTEarnings Window
    2026-07-10 21:05 UTCEVENTEarnings Window
    2026-07-06 03:50 UTCNEWSUnitedHealth Group Q2 earnings preview: Medical cost trends and margin outlook in focus → Investors await the insurer’s second-quarter results, with attention centered on medical loss ratio stability and full-year guidance amid a volatile healthcare environment.
    2026-06-29 21:22 UTCNEWSLuigi Mangione trial delayed to January → Judge pushes back federal proceedings in UnitedHealthcare CEO killing case, extending legal uncertainty for the insurer.
    2026-06-26 03:13 UTCHOLDERInstitutional holding changed
    2026-06-26 03:13 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-24 03:12 UTCHOLDERInstitutional holding changed
    2026-06-24 03:12 UTCHOLDER1 institutional position change flagged (1 major)
    2026-05-21 05:42 UTCFILINGRegulatory filing →
    2026-05-01 02:36 UTCFILINGRegulatory filing →
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage